Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315
Clinical trial NCT06592495 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06592495
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2025-01-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.